Last updated on 3 Jan 2024
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2169417 filed on 10 Feb 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2169417
10 Feb 2021
10 Feb 2031
FIGURATIVE
11 Aug 2020
US
Status Date | Action Taken |
---|---|
3rd Jan 2024 | IP Right Goods and Services Items updated |
3rd Jan 2024 | IP right goods and service classes updated |
24th Jun 2021 | International Registration in Australia Protected correspondence sent |
23rd Jun 2021 | IP Right Registration Published |
23rd Jun 2021 | Status change to Registered/Protected |
17th Apr 2021 | Application Accepted correspondence sent |
16th Apr 2021 | IP Right has been Examined |
16th Apr 2021 | IP Right Acceptance Published |
16th Apr 2021 | Status change to Accepted |
13th Apr 2021 | Awaiting examination |